| Document Date: 2012-10-04 17:58:42
Open Document File Size: 115,50 KBShare Result on Facebook
City Chest Physicians Evidence / Wayne / / Company Bayer Healthcare Pharmaceuticals / M.D. / / Country United States / / Facility American College of Chest Physicians Evidence-Based Clinical Practice Guidelines / / IndustryTerm manufacturing / thirdparty manufacturer / / MedicalCondition hemothorax / Serious anaphylactic reactions / epistaxis / pneumonia / unspecified infections / hematuria / shock / Prevention Of Thrombosis / cerebrovascular accident / stroke / pericardial effusion / thrombocytopenia / fever / severe uncontrolled hypertension / renal insufficiency / heart failure / allergic reactions / liver cirrhosis / ventricular fibrillation / anaphylactic reactions / hypersensitivity / thromboembolic disease / active peptic ulcer / Serious liver injury / bacterial endocarditis / heparin-induced thrombocytopenia / anemia / hemorrhagic diathesis / sepsis / / MedicalTreatment thrombolytic therapy / major surgery / surgery / / Organization Food and Drug Administration / American College of Chest Physicians Evidence-Based Clinical Practice Guidelines / / Person Joseph Germino / / / Position treating physician / Vice President U.S. Medical Affairs / / Product Refludan / vitamin K / discontinue marketing Refludan / / Technology antibodies / /
SocialTag |
Dear Health Care Professional Letter Refludan 2012 final